verapamil has been researched along with nps-568 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boblewski, K; Dyś, A; Lehmann, A; Lewko, B; Marchwińska, A; Rybczyńska, A; Szczoczarz, A | 1 |
1 other study(ies) available for verapamil and nps-568
| Article | Year |
|---|---|
Verapamil prevents the effect of calcium-sensing receptor activation on the blood glucose and insulin levels in rats.
Topics: Animals; Blood Glucose; Calcium; Calcium Channel Blockers; Glucose; Insulin; Insulin Secretion; Male; Naphthalenes; Phenethylamines; Propylamines; Rats; Rats, Wistar; Receptors, Calcium-Sensing; Verapamil | 2019 |